| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 09/18/2002 | EP1240330A2 i PSEUDOMONAS AERUGINOSA /i ANTIGENS |
| 09/18/2002 | EP1240329A2 i STREPTOCOCCUS PNEUMONIAE /i ANTIGENS |
| 09/18/2002 | EP1240328A1 Antigenic protein lppq of mycoplasma mycoides subsp. mycoides sc., its preparation and use |
| 09/18/2002 | EP1240327A2 Interferon-like molecules and uses thereof |
| 09/18/2002 | EP1240326A2 Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells, and antibodies that identify the same |
| 09/18/2002 | EP1240323A2 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors |
| 09/18/2002 | EP1240319A1 Shotgun scanning, a combinatorial method for mapping functional protein epitopes |
| 09/18/2002 | EP1240310A2 Method of inactivating microorganisms |
| 09/18/2002 | EP1240202A2 Inhibitors of complement activation, their preparation and use |
| 09/18/2002 | EP1240197A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 09/18/2002 | EP1240195A2 Polynucleotides and polypeptides encoded thereby |
| 09/18/2002 | EP1240189A2 Hepatitis virus sentinel virus i (svi) |
| 09/18/2002 | EP1240183A2 Mammalian genes; related reagents and methods |
| 09/18/2002 | EP1239870A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 09/18/2002 | EP1239869A2 Tweak receptor |
| 09/18/2002 | EP1088095A4 Novel molecules of the t110-related protein family and uses thereof |
| 09/18/2002 | EP0842267B1 Mch2, AN APOPTOTIC CYSTEINE PROTEASE, AND COMPOSITIONS FOR MAKING AND METHODS OF USING THE SAME |
| 09/18/2002 | EP0789763B1 Icam-4 materials and methods |
| 09/18/2002 | EP0693936B1 Cloned leptospira outer membrane protein |
| 09/18/2002 | EP0614486B1 Targeted delivery of virus vector to mammalian cells |
| 09/18/2002 | EP0592582B1 Monoclonal antibody to lymphocyte-associated cell surface protein |
| 09/18/2002 | EP0575357B1 Human follicle stimulating hormone receptor |
| 09/18/2002 | EP0537171B1 CD46 isoforms |
| 09/18/2002 | CN1370238A Human poly(ADP-ribose) polymerase 2 materials and methods |
| 09/18/2002 | CN1370233A ERS-genes, method of screening for chemical compounds capable of inducing ERS in plants |
| 09/18/2002 | CN1370232A Methods for making APO-2 ligand using divalent metal ions |
| 09/18/2002 | CN1370231A CASB618 polynucleotides and polypeptides and their use |
| 09/18/2002 | CN1370229A Nucleic acid fragment and vector contg. halogenase and method for halogenation of chemical compounds |
| 09/18/2002 | CN1370182A Compounds and methods for therapy and diagnosis of lung cancer |
| 09/18/2002 | CN1370078A Prion protein peptides and uses thereof |
| 09/18/2002 | CN1369506A Human Protein for promoting transform of 3T3 cell and its coding sequence |
| 09/18/2002 | CN1369505A Human protein for promoting transform of 3T3 cell and its coding sequence |
| 09/17/2002 | US6451997 Kits for detecting chromosomal rearrangements |
| 09/17/2002 | US6451993 Polynucleotides encoding human excitatory amino acid transporter 4 (EAAT4) |
| 09/17/2002 | US6451982 Polypeptide with amino acid sequences grafted into human heavy and light chain variable regions |
| 09/17/2002 | US6451981 Inhibitor of cellular adhesion, migration or infiltration into areas of tissue damage, injury, or transplant |
| 09/17/2002 | US6451764 VEGF-related protein |
| 09/17/2002 | US6451760 Treatment of inflammation using a 2F1 polypeptide or an antibody thereto |
| 09/17/2002 | US6451597 Method for enhanced protein stabilization and for production of cell lines useful for production of such stabilized proteins |
| 09/17/2002 | US6451582 Staphylococcus strains comprising an inducible gene encoding an RNA polymerase specificity factor |
| 09/17/2002 | US6451577 Human uridine disphosphate galactose-4-epimerase |
| 09/17/2002 | US6451575 The invention is directed to the family of aggrecan degrading metallo proteases (admps) that exhibit the ability to cleave the aggrecan core protein between amino acid residues glu.sup.373 -ala.sup.374. the invention encompasses the |
| 09/17/2002 | US6451573 Proteinase inhibitor, precursor thereof and genetic sequences encoding same |
| 09/17/2002 | US6451561 Growth hormone variants |
| 09/17/2002 | US6451560 Prokaryotic expression system characterized by alterations to the dlt operon whereby expression of genes encoded therein may be regulated to limit the availability of polypeptides encoded by said genes. |
| 09/17/2002 | US6451559 Expression vector for improved production of polypeptides in yeast |
| 09/17/2002 | US6451557 Method for producing, in yeast, a hydroxylated triple helical protein, and yeast host cells useful in said method |
| 09/17/2002 | US6451554 Purified nucleic acid sequence encoding a sodium channel protein wherein said nucleic acid sequence comprises the coding portion of the nucleic acid sequence and producing a mammalian sensory neuron sodium channel protein, wherein the |
| 09/17/2002 | US6451547 Process for differential diagnosis of Alzheimer's dementia and device therefor |
| 09/17/2002 | US6451546 Plant glurs of the invention may function as signal transducers involved in the regulation of plant growth. the invention also relates to the identification of compounds that modulate the activity of the plant glur and herbicides |
| 09/17/2002 | US6451545 Monoclonal antibody specific to anti-human fibrin monomer, process for producing the same, hybridomas, and immunoassay method |
| 09/17/2002 | US6451541 Chaperones capable of binding to prion proteins and distinguishing the isoforms PrPc and PrPsc |
| 09/17/2002 | US6451539 Expression vectors, transfection systems, and method of use thereof |
| 09/17/2002 | US6451534 Kvlqt1 and kcne1 which are genes associated with long qt syndrome. additional sequence data for the two genes are also disclosed. mutations in kvlqt1 which result in long qt syndrome. the intron/exon junction sequence data allow for the |
| 09/17/2002 | US6451523 Variant form of the receptor for the obese gene product. the invention relates to methods of detecting this receptor variant in cells and tissues of obese individuals. |
| 09/17/2002 | US6451522 Combining agent to be tested, antibody or antigen-binding fragment which binds to amino terminal domain of mammalian cc-chemokine receptor 2, mammalian cc-chemokine receptor 2 or ligand-binding variant, measuring binding |
| 09/17/2002 | US6451315 Compounds and methods for the diagnosis and treatment of B. microti infection |
| 09/17/2002 | US6451313 Heterotetramer; expression vectors encoding heavy and light chains; viricides |
| 09/17/2002 | US6451312 Diagnosis, imaging; induction of endothelial cell surface antigens |
| 09/17/2002 | US6451311 An antibody which binds procalcitonin but not free calcitonin, free katacalcin and free n-procalcitonin; used as an in vitro or in vivo diagnostic agent |
| 09/17/2002 | US6451310 Preventing t cell activation of b cells by administering antibody cabable of binding protein recognized by monoclonal antibody 5c8 |
| 09/17/2002 | CA2243459C Human antibodies that bind human tnf.alpha. |
| 09/17/2002 | CA2213001C Isolated nucleic acid molecule encoding peptides which form complexes with mhc molecule hla-cw*1601 and uses thereof |
| 09/17/2002 | CA2204151C Cdna encoding a bmp type ii receptor |
| 09/17/2002 | CA2187908C Non-splicing variants of gp350/220 |
| 09/17/2002 | CA2122036C Bacterial nitroreductase for the reduction of cb 1954 and analogues thereof to a cytotoxic form |
| 09/17/2002 | CA2111853C Substantially pure receptor like tgf-.beta.1 binding molecules and uses thereof |
| 09/17/2002 | CA2067919C Heterobifunctional antibodies possessing dual catalytic and specific antigen binding properties and methods using them |
| 09/17/2002 | CA2047244C Genetically engineered immunoglobulins |
| 09/17/2002 | CA2038667C Process for the preparation of mannosyl teicoplanin derivatives and mannosyl teicoplanin aglycone |
| 09/16/2002 | CA2373468A1 Reg-like protein |
| 09/12/2002 | WO2002070722A1 Use of fusion proteins whose n-terminal part is a hirudin derivative for the production of recombinant proteins via secretion by yeasts |
| 09/12/2002 | WO2002070713A2 Dna sequence from kluyveromyces marxianus comprising regulatory regions for expressing proteins |
| 09/12/2002 | WO2002070711A1 Vaccine |
| 09/12/2002 | WO2002070708A2 Glutamate receptor modulatory proteins and nucleic acids encoding them |
| 09/12/2002 | WO2002070706A2 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 09/12/2002 | WO2002070700A1 Polynucleotide useful for modulating cancer cell proliferation |
| 09/12/2002 | WO2002070698A2 Modified ciliary neurotrophic factor (cntf) with reduced immunogenicity |
| 09/12/2002 | WO2002070672A2 Plant cell having animal-type sugar chain adding function |
| 09/12/2002 | WO2002070669A2 Secreted proteins |
| 09/12/2002 | WO2002070667A2 High level insect expression of rage proteins |
| 09/12/2002 | WO2002070665A2 Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen |
| 09/12/2002 | WO2002070657A2 93870, a human g-protein coupled receptor and uses therefor |
| 09/12/2002 | WO2002070655A2 Mouse cytokine receptor |
| 09/12/2002 | WO2002070648A2 Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates |
| 09/12/2002 | WO2002070645A2 Functional surface display of polypeptides |
| 09/12/2002 | WO2002070565A2 High-affinity antagonists of elr-cxc chemokines |
| 09/12/2002 | WO2002070556A1 POLYPEPTIDE OF A P53 PROTEIN-SPECIFIC MURINE Α/β T-CELL RECEPTOR, NUCLEIC ACIDS CODING THEREFOR AND USE THEREOF |
| 09/12/2002 | WO2002070553A1 Tumour peptide antigen produced from human mdm2 proto-oncogene |
| 09/12/2002 | WO2002070552A2 POLYPEPTIDE FROM A HDM2 PROTEIN SPECIFIC MURINE Α/β T-CELL RECEPTORS, NUCLEIC ACIDS CODING FOR THE ABOVE AND USE THEREOF |
| 09/12/2002 | WO2002070006A2 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses |
| 09/12/2002 | WO2002069997A1 Modified protamine with reduced immunogenicity |
| 09/12/2002 | WO2002069907A2 Anti-neovasculature preparations for cancer |
| 09/12/2002 | WO2002069900A2 Methods for treating genetically-defined proliferative disorders with hsp90 inhibitors |
| 09/12/2002 | WO2002069886A2 Modified proteins, designer toxins, and methods of making thereof |
| 09/12/2002 | WO2002063010A9 Method of producing recombinant antibodies against tumors |
| 09/12/2002 | WO2002052012A3 Sugar beet genes involved in stress tolerance |
| 09/12/2002 | WO2002022680A3 Site-specific, antibody-mediated activation of proapoptotic cytokine: amaice (antibody-mediated apoptosis inducing cytokine) |
| 09/12/2002 | WO2002014369A3 Human kininogen d5 domain polypeptides and their use |
| 09/12/2002 | WO2001092543A3 Improved methods of transfection |